Official Journal of Research Center for Gastroenterology and Liver Diseases
Non-alcoholic steatohepatitis: An update in pathophysiology, diagnosis and therapy
Authors
Abstract
Non-alcoholic steatohepatitis (NASH), first described by Ludwig et al, in 1980, is a stage in the wide spectrum of non-alcoholic fatty liver diseases (NAFLDs) and one of the leading causes of chronic liver disease. Several scientists have tried to more distinctly discover and describe different aspects of NASH. In contrast with its counterpart in the NAFLDs-the NAFL-NASH consists of inflammation as well as necrosis in the liver tissue resulting in a poor outcome. NASH is also a known etiology for cryptogenic liver cirrhosis. Evidence suggests that cirrhosis developing due to NASH have a relatively worse outcome compared to that of hepatitis C-related cirrhosis. In this review article, we try to review and present all relevant articles about NASH.
Highlights
Copyright
© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review
Arabi M, Alimoradzadeh R, Makian A, Shariat Nabavi SJ, Divsalar F, et al. Non-alcoholic Steatohepatitis Diagnosis and Treatment Medical and Surgery, Based on Guideline Updates: A Mini Review. J Health Rep Technol. 2022;8(3):e119454. doi: https://doi.org/10.5812/jhrt-119454
Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis
Zhao Y, Zhan X, Zhang Y. Outcomes of Non-Alcoholic Steatohepatitis Patients After Liver Transplantation: A Systematic Review and Meta-Analysis. Hepat Mon. 2019;19(4):e82336. doi: https://doi.org/10.5812/hepatmon.82336
Non-Alcoholic Fatty Liver Disease: Diagnosis and Evaluation of Disease Severity
Jamali R. Non-Alcoholic Fatty Liver Disease: Diagnosis and Evaluation of Disease Severity. Thrita J Neu. 2013;2(4):43-51. doi: https://doi.org/10.5812/thrita.11795
Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic “Mal-Programming”
Manti S, Romano C, Chirico V, Filippellii M, Cuppari C, et al. Nonalcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Childhood: Endocrine-Metabolic “Mal-Programming”. Hepat Mon. 2014;14(5):e93068. doi: https://doi.org/10.5812/hepatmon.17641
Clinico- biochemical comparison of patients with Nonalcoholic fatty liver disease and healthy populace
Khoshbaten M, Fatahi E, Soomi H, Tarzmani M, Farhang S, et al. Clinico- biochemical comparison of patients with Nonalcoholic fatty liver disease and healthy populace. Zahedan J Res Med Sci. 2009;11(1):e94431. doi:
- Scopus by DOI: 0
Last Update: 3 weeks ago
- Scopus by Title: 12
Last Update: 3 weeks ago
- Scopus by Title (Ref): 12
Last Update: 3 weeks ago
- CrossRef: 0
Last Update: 7 hours ago
- OpenAlex: 0
Last Update: 9 hours ago
- OpenCitations: 0
Last Update: 4 days ago